Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/sciences-de-la-vie/cancer-immunotherapy/descriptif_3822069
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3822069

0 article 

 Frais de port 0,01€*

Exclusivité web : à partir de 35 euros d’achat, frais de port à 1 centime pour les expéditions vers la France métropolitaine, la Suisse et l’UE avec Colissimo ou GLS

Cancer Immunotherapy Progress in Molecular Biology and Translational Science Series

Langue : Anglais

Coordonnateur : Teplow David B.

Couverture de l’ouvrage Cancer Immunotherapy

Cancer Immunotherapy, Volume 165 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to different approaches to cancer immunotherapy, with this release focusing on TNFR2 in cancer immunology and immunotherapy, From the Hellstrom paradox towards cancer cure, CAR T-cell treatment of T-cell malignancy , Immunotherapy of pancreatic cancer, Cancer stem cell immunology/immunotherapy,

Cytokine release syndrome, Tumor cell-based mechanisms of resistance to immune attack, and Mushroom compounds in cancer immunotherapy.

1. TNFR2 in cancer immunology and immunotherapy Xin Chen 2. From the Hellstrom paradox towards cancer cure Ingegerd Hellstrom and Karl Erik Hellstrom 3. CAR T-cell treatment of T-cell malignancy Martin Pule 4. Immunotherapy of pancreatic cancer Jorg Kleeff 5. Cancer stem cell immunology/immunotherapy Federica Cavallo 6. Cytokine release syndrome Alexander Shimabukuro-Vornhagen 7. Tumor Cell-Based Mechanisms of Resistance to Immune Attack Louis M. Weiner 8. Mushroom compounds in cancer immunotherapy Peter Amwoga Ayeka

Each volume of Progress in Molecular Biology and Translational Science will be useful for scientists working actively in a field, including those at levels ranging from graduate student to senior investigator. Volumes also are appropriate for new investigators to a field who wish to familiarize themselves with the latest work.

Professor Teplow is a member of the Department of Neurology, David Geffen School of Medicine at UCLA; Director, UCLA Biopolymer Laboratory; and a member of the faculties of the Molecular Biology Institute, Brain Research Institute, Chemistry-Biology Interface Training Program, and various neuroscience graduate programs. Professor Teplow received degrees in Biochemistry, and in Bacteriology & Immunology, from UC Berkeley; a Ph.D. from the University of Washington, Seattle; and postdoctoral training at the California Institute of Technology, Pasadena, CA. From 1991-2005, Professor Teplow was a member of the faculty of the Department of Neurology, Harvard Medical School, Boston. Professor Teplow has published >200 peer-reviewed articles, including ~150 original articles and ~50 reviews, book chapters, and commentaries. Professor Teplow was a founding editor of the Journal of Molecular Neuroscience and Current Chemical Biology. He currently is Associate Editor-in-Chief of the American Journal of Neurodegenerative Disease. Professor Teplow is a member of numerous national and international scientific advisory and editorial boards.
  • Includes comprehensive coverage of molecular biology
  • Presents ample use of tables, diagrams, schemata and color figures to enhance the reader's ability to rapidly grasp the information provided
  • Contains contributions from renowned experts in the field

Date de parution :

Ouvrage de 354 p.

15x22.8 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

166,19 €

Ajouter au panier

Thèmes de Cancer Immunotherapy :